Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Intervenciones no médicas para mejorar la reincorporación al trabajo de las personas con cáncer

Información

DOI:
https://doi.org/10.1002/14651858.CD007569.pub4Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 05 marzo 2024see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud laboral

Copyright:
  1. Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Angela GEM de Boer

    Correspondencia a: Department of Public and Occupational Health, University of Amsterdam, Amsterdam Public Health Research Institute, Coronel Institute of Occupational Health, Amsterdam UMC, Location AMC, Amsterdam, Netherlands

    [email protected]

  • Sietske J Tamminga

    Department of Public and Occupational Health, University of Amsterdam, Amsterdam Public Health Research Institute, Coronel Institute of Occupational Health, Amsterdam UMC, Location AMC, Amsterdam, Netherlands

  • Julitta S Boschman

    Cochrane Work, Department of Public and Occupational Health, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, Location AMC, Amsterdam, Netherlands

  • Jan L Hoving

    Cochrane Work, Department of Public and Occupational Health, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, Location AMC, Amsterdam, Netherlands

Contributions of authors

Update 2024

AdB is the main review author. She designed and conducted the search strategy, ran the analyses, wrote the draft of the updated review and revised it against editorial and peer‐review comments.

ST checked studies for eligibility, conducted data extraction and assessed included studies for risk of bias. She provided feedback during the review development process.

JB conducted the searches with the clinical librarian, checked studies for eligibility, conducted data extraction, assessed included studies for risk of bias, performed GRADE data synthesis and provided feedback during the review development process.

JH checked studies for eligibility, conducted data extraction, assessed included studies for risk of bias and provided feedback during the review development process.

Original review and 2015 update

AdB was the main review author and was involved with all aspects of the protocol. She wrote the protocol and the review. She designed and conducted the search strategy.

TT, ST, MF‐D, MF and JV contributed to the draft version of the protocol and review.

AdB and TT screened eligible studies, conducted the quality assessment of eligible studies and extracted data from the included studies.

JV and AdB conducted the data synthesis.

JV performed GRADE data synthesis.

Sources of support

Internal sources

  • Coronel Institute of Occupational Health, Department of Public and Occupational Health, Netherlands

    Personnel

  • Cochrane Occupational Safety and Health Review Group, Finland

    Personnel

  • University of Birmingham, UK

    Personnel

  • Uniformed Services University of the Health Sciences, USA

    Personnel

  • Centre for Workforce Effectiveness, The Work Foundation, London, UK

    Personnel

External sources

  • SIG Pathways to Work. University Research Programme, Netherlands

    Personnel

  • Finnish Work Environment Fund, Finland

    Personnel

  • COST Action CANWON IS1211, Other

    Meetings

Declarations of interest

AdB: no relevant interests; involved in conducting Tamminga 2013 (GAK (social insurance) Foundation), Greidanus 2021 (Dutch Cancer Society), Zaman 2021 (Dutch Cancer Society); Tamminga 2013: co‐author, academic medical hospital Amsterdam; Greidanus 2021: co‐author, academic medical hospital Amsterdam; Zaman 2021: co‐author, academic medical hospital Amsterdam.

ST: no relevant interests; involved in conducting Tamminga 2013 (GAK (social insurance) Foundation), Greidanus 2021 (Dutch Cancer Society); Tamminga 2013: co‐author; academic medical hospital Amsterdam; Greidanus 2021: co‐author, academic medical hospital Amsterdam.

JB: Knowledge Institute of the Dutch Association of Medical Specialists (Senior Advisor); former Managing Editor of Cochrane Work, Amsterdam UMC, Amsterdam, Netherlands.

JH: no relevant interests; currently Coordinating Editor of Cochrane Work, Amsterdam UMC, Amsterdam, Netherlands.

JB and JH excluded themselves entirely from the editorial process to ensure independence. Review authors were not involved in the study selection, data extraction, risk of bias or GRADE assessment for studies where they were also involved as study co‐authors.

Acknowledgements

We are grateful to MC Jong, LQ Rogers, S Singer, S Tamminga and S Duijts for kindly providing further information about their studies.

We would like to acknowledge the contribution of Jos Verbeek, Monique Frings‐Dresen, Taina Taskila and Michael Feuerstein as authors of the previous two versions of this review.

Cochrane Work supported the authors in the development of this review update. Joost Daams kindly conducted the search update and we are very grateful for the help of Christina Tikka Mischke. Jan Hoving is a member of Cochrane Work but was not involved in the editorial process or decision‐making for this review update. The following people conducted the editorial process for this update.

  • Sign‐off Editor (final editorial decision): Lisa Bero, University of Colorado Anschutz Medical Campus

  • Managing Editor (selected peer reviewers, collated peer‐reviewer comments, provided editorial guidance to authors, edited the article): Joey Kwong, Cochrane Central Editorial Service

  • Editorial Assistant (conducted editorial policy checks and supported editorial team): Leticia Rodrigues, Cochrane Central Editorial Service

  • Copy Editor (copy‐editing and production): Anne Lawson, Cochrane Central Production Service

  • Peer‐reviewers (provided comments and recommended an editorial decision): Bogda Koczwara, Flinders University and Flinders Medical Centre, Adelaide, Australia (clinical/content review); Ingrid G Boelhouwer, Department of Applied Psychology, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands (clinical/content review); Chia Jie Tan, University of Utah College of Pharmacy (clinical/content review), Elanga Andrea Ornela, Communication officer at eBASE Africa (consumer review); Kerry Dwan, Rachel Richardson, Sofia Tsokani, Cochrane Methods Support Unit (methods reviews); Robin Featherstone, Cochrane Evidence Production & Methods Directorate (search review)*. *One additional peer reviewer provided search peer review, but chose not to be publicly acknowledged.

Version history

Published

Title

Stage

Authors

Version

2024 Mar 05

Non‐medical interventions to enhance return to work for people with cancer

Review

Angela GEM Boer, Sietske J Tamminga, Julitta S Boschman, Jan L Hoving

https://doi.org/10.1002/14651858.CD007569.pub4

2015 Sep 25

Interventions to enhance return‐to‐work for cancer patients

Review

Angela GEM de Boer, Tyna K Taskila, Sietske J Tamminga, Michael Feuerstein, Monique HW Frings‐Dresen, Jos H Verbeek

https://doi.org/10.1002/14651858.CD007569.pub3

2011 Feb 16

Interventions to enhance return‐to‐work for cancer patients

Review

Angela GEM de Boer, Taina K Taskila, Sietske J Tamminga, Monique HW Frings‐Dresen, Michael Feuerstein, Jos H Verbeek

https://doi.org/10.1002/14651858.CD007569.pub2

2009 Jan 21

Interventions to enhance return‐to‐work for cancer patients

Protocol

Angela GM de Boer, Taina Taskila, Sietske J Tamminga, Monique HW Frings‐Dresen, Michael Feuerstein, Jos H Verbeek

https://doi.org/10.1002/14651858.CD007569

Differences between protocol and review

2024 update

For this updated review version, we made several amendments from the protocol (de Boer 2009b).

  • We excluded seven RCTs from the first two versions of this review (de Boer 2011; de Boer 2015), because in this update we focussed on interventions that can be launched to enhance RTW in people with cancer, regardless of medical treatment. These seven excluded RCTs concerned solely medical and pharmaceutical interventions.

  • Accordingly, the objectives of this review version have been changed to: To evaluate the effectiveness of non‐medical interventions aimed at enhancing return to work (RTW) in people with cancer compared to alternative programmes including usual care or no intervention. See Objectives.

  • We did not use the OSH‐ROM database because it is not supported by our organisation.

  • We did not used the DARE database because no new records have been published to DARE since 2015.

  • We visually inspected forest plots for similarity of point estimates to indicate statistical heterogeneity. We assessed publication bias by visually inspecting funnel plot asymmetry when at least 10 RCTs were available in the meta‐analysis, because when there are fewer studies the power of the tests is low. This is in line with the Cochrane Handbook for Systematic Reviews of Interventions. However, this is a deviation from the protocol when we stated a minimum of five studies was needed for a funnel plot test (de Boer 2009b).

  • We did not pool the QoL outcomes of Purcell 2011, because the outcomes were reported as medians and IQRs.

  • We excluded Rogers 2009, which was included in previous review versions (de Boer 2011; de Boer 2015), because the RTW outcomes were reported as a mean change in the number of sick leave days instead of the number of sick leave days.

  • For cluster‐RCTs, we assessed five additional domains of risk of bias (Richardson 2016): recruitment bias (differential participant recruitment in clusters for different interventions); baseline imbalance; loss of clusters; incorrect analysis; and comparability with individually randomised trials.

Note: in the next update of this review, we will assess risk of bias in included studies using the Cochrane RoB 2 tool as per guidance in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2023).

2015 update

For the 2015 updated review version (de Boer 2015), we made several amendments.

  • We excluded non‐randomised studies because it was clear that randomised studies are feasible and have been conducted. This proved that our earlier understanding was mistaken in that it would be difficult to randomise in this context. This had been the main reason for including non‐randomised studies.

  • Work retention was not considered a primary outcome because the aim of this review was to evaluate the effectiveness of interventions aimed at enhancing RTW not on work retention. The primary outcome was instead: RTW measured as event data such as the number of people who RTW.

  • We added physical interventions to the type of interventions included in this review due to clinical relevance. They were not listed in the protocol.

  • Subgroup analyses according to setting and quality of study were no longer planned.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.